In summary, this longitudinal study performed in a healthy, rural, Korean population revealed that changes in circulating adiponectin level over 2.4 years of follow-up, as well as adiponectin levels at the baseline, were independently associated with a lower risk of MetS. The gene discussed is ADIPOQ; the disease is metabolic syndrome.